
Lasa Supergenerics Ltd
BSE : 540702|NSE : LASA|ISIN : INE670X01014
Lasa Supergenerics Ltd Company History
Lasa Supergenerics is primarily engaged in the business of manufacturing API bulk drugs products.
2021
2021
LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.
2021